Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Leukemia, T-Cell × Melphalan × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Multiple Myeloma 3 Neoplasms, Neuroepithelial 1 Lymphoma, T-Cell 1 Lymphoma, B-Cell 1 Leukemia, T-Cell 1 Burkitt Lymphoma 1

Interventions

fludarabine 1 Melphalan 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04264078 2021-06-28

Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies

Xinqiao Hospital of Chongqing

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, T-Cell, Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡